Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy

British Journal of Dermatology

Volumn 136, Issue 5, 1997, Pages 737-742

  Tausch, I ^a,b   Brautigam M ^c   Weidinger, G ^c   Jones, T C ^d  

^a HUMBOLDT UNIVERSITY   (Germany)

^b BioSkin   (Germany)

^c Department Clinical Research   (Germany)

^d Clinical Research Consultants   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TERBINAFINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; ONYCHOMYCOSIS; PRIORITY JOURNAL; SKIN TOXICITY;

EID: 0030926288     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb03662.x     Document Type: Article

References (11)

1. Stütz A. The discovery and chemistry of terbinafine. In: Cutaneous Antifungal Agents (Rippon JW, Fromtling RA, eds). New York: Marcel Dekker, 1993: 117-26.
2. Ryder N, Terbinafine: mode of action and properties of the squalene epoxidase inhibition. Br J Dermatol 1992; 126 (Suppl. 39): 2-7.
3. Petranyi G, Meingassner JG, Mieth H. Antifungal activity of the allylamine derivatives in vitro. Antimicrob Agents Chemother 1987; 31: 1365-8.
4. Evans EGV, Dodman B, Williamson DM et al. Comparison of terbinafine and clotrimazole in treating tinea pedis. Br Med J 1993; 307: 645-7.
5. Evans EGV, Seaman RAJ, James IGV. Short-duration therapy with terbinafine 1% cream in dermatophyte infections. Br J Dermatol 1994; 130: 83-7.
6. Faergeman J, Zehender H, Millerioux L. Levels of terbinafine in plasma, stratum corneum, sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days. Clin Exp Dermatol 1994; 19: 121-6.
7. Finlay AY. Pharmacokinetics of terbinafine in nail. Br J Dermatol 1992; 126 (Suppl. 39): 28-32.
8. Schatz F, Bräutigam M, Dobrowolski E et al. Nail incorporation kinetics of terbinafine in onychomycosis patients. Clin Exp Dermatol 1995; 20: 377-83.
9. Anderson DW. Griseofulvin: biology and clinical usefulness. Ann Allergy 1965; 23: 103-10.
10. Van der Schroeff JG, Cirkel PKS, Crijns MB et al. A randomized treatment duration-finding study of terbinafine in onychomycosis. Br J Dermatol 1992; 126 (Suppl. 39): 36-9.
11. Bräutigam M, Nolting S, Schopf RE, Weidinger G. Randomized double-blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Br Med J 1995; 311: 919-22. Published erratum appears in Br Med J 1995; 311: 1350.